Yifei (Efay) Liu, B.S.Pharm, Ph.D.
UMKC School of Pharmacy
2464 Charlotte St.
Kansas City, MO 64108
Dr. Liu is a tenured associate professor at The University of Missouri – Kansas City (UMKC) School of Pharmacy, and a Graduate and Doctoral Faculty Member at UMKC Henry W. Bloch School of Management. He has a B.S. in Pharmacy from West China University of Medical Sciences, and an M.S. and a Ph.D. in Pharmaceutical Socioeconomics from The University of Iowa. Dr. Liu has had over 30 peer-reviewed journal publications, and a book chapter titled “Pharmacists and U.S. Health Care” in the book of Pharmacy and the U.S. Health Care System (4th ed.). Dr. Liu has taught a multitude of topics in the areas of U.S. health care system, health care marketing, pharmacy practice management, health economics, and health care policy. He also serves as an Associate Faculty in Post Graduate Year 2 (PGY-2) Western Missouri Psychiatric Residency Program at Center for Behavioral Medicine, and a preceptor in Post Graduate Year 1 (PGY-1) Community Pharmacy Residency Program at UMKC. Dr. Liu is an editorial board member of Advances in Therapy and Research in Social and Administrative Pharmacy, and an advisory board member of Dermatology and Therapy. He was an editorial member of Journal of the American Pharmacists Association from 2014 to 2017. In addition, he has been a peer reviewer for 17 journals. At UMKC, Dr. Liu has served on multiple committees such as School of Pharmacy Committee of Promotion and Tenure, School of Pharmacy Research Advisory Council, School of Pharmacy Committee of Graduate Programs, and UMKC Interdisciplinary Ph.D. Executive Committee. He is the President of UMKC Chinese Scholars Association from 2017 to 2018.
1. Behaviors of patients or health providers in the health care system, including (1) the collaboration between pharmacists and other health providers, (2) patients’ search for health information, and (3) the application of the Theory of Planned Behavior (TPB).
2. Marketing activities in the health care system, including (1) the implementation, marketing, and evaluation of pharmacy services, and (2) the impact of direct-to-consumer advertising of prescription drugs.
3. Patients’ health outcomes, including (1) patients’ utilization of emergency department and hospitalization, (2) outcomes of using medications such as adherence, and (3) maternal and child health outcomes.